Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00579566 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT00579566 · ClinicalTrials.gov record · last posted 2026-07-30

Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma

StatusRecruiting
PhaseNot specified
Started2002-06
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The purpose of this study is to study normal and sarcoma cells. To study these cells we need to have human tissue. You will be having or have already had a procedure to remove tissue. We would like to use some of this tissue. We will use it for laboratory studies on the diagnosis,behavior and treatment of sarcoma. We will perform an extensive analysis of your samples. We will only use extra tissue left over after all needed testing has been done or remove an additional small amount of tissue if you are having a biopsy. We will also take blood samples before and/or after your procedure to measure biochemical factors that may help us predict the behavior of sarcoma.

Protocol amendment history 2 changes detected by DataLookout

2026-07-31
critical
Primary completion pushed: 2026-06 → 2027-06
2026-07-31
minor
Completion pushed: 2026-06 → 2027-06
Trial Details
NCT Number NCT00579566
Lead Sponsor Memorial Sloan Kettering Cancer Center
Conditions Sarcoma
Enrollment 3,000 participants
Start Date 2002-06
Primary Completion 2027-06 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-07-30